POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES

POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES was reported 803 times

POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DIABETIC COMPLICATION RENAL 1 0.1667
1 ACTIVATED PROTEIN C RESISTANCE 1 0.0303
2 TYPICAL AURA WITHOUT HEADACHE 2 0.0204
3 RECTAL PROLAPSE REPAIR 1 0.0189
4 ESCHERICHIA PERITONITIS 1 0.0182
5 POLYMERS ALLERGY 1 0.0145
6 PRODUCT INTOLERANCE 2 0.0090
7 SACROILIAC JOINT DYSFUNCTION 1 0.0075
8 UMBILICAL HAEMORRHAGE 1 0.0066
9 RECTAL LESION 1 0.0064
10 DISTAL INTESTINAL OBSTRUCTION SYNDROME 2 0.0059
11 BLADDER OBSTRUCTION 3 0.0058
12 ARTERIOVENOUS FISTULA OCCLUSION 1 0.0057
13 BLOOD COPPER INCREASED 1 0.0056
14 TANGENTIALITY 1 0.0052
15 PRODUCT DISPENSING ERROR 97 0.0044
16 RETINAL DYSTROPHY 1 0.0042
17 PERITONEAL EFFLUENT ABNORMAL 1 0.0037
18 OVERGROWTH BACTERIAL 1 0.0037
19 ARTERIOVENOUS FISTULA OPERATION 1 0.0037
20 ANTICOAGULANT THERAPY 1 0.0035
21 URINARY TRACT INFECTION PSEUDOMONAL 2 0.0033
22 EYE ABSCESS 1 0.0033
23 ANALGESIC THERAPY 1 0.0031
24 BLOOD CREATINE PHOSPHOKINASE DECREASED 1 0.0030
25 ABDOMINOPLASTY 1 0.0030
26 DIALYSIS RELATED COMPLICATION 1 0.0028
27 PRODUCT DOSE CONFUSION 1 0.0028
28 HERPES ZOSTER MENINGOENCEPHALITIS 1 0.0028
29 CHRONIC LEFT VENTRICULAR FAILURE 1 0.0028
30 SCAR PAIN 1 0.0025
31 TOOTH EROSION 3 0.0024
32 HOMELESS 1 0.0022
33 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 2 0.0022
34 ADENOCARCINOMA GASTRIC 2 0.0022
35 URINARY TRACT PAIN 1 0.0020
36 FEMALE STERILISATION 1 0.0019
37 BONE DEMINERALISATION 2 0.0019
38 CONTRAINDICATED PRODUCT PRESCRIBED 3 0.0018
39 HEAD BANGING 1 0.0018
40 CHEMICAL BURN 2 0.0017
41 CATARACT NUCLEAR 1 0.0015
42 PRODUCT PRESCRIBING ERROR 35 0.0015
43 CERVICAL RADICULOPATHY 1 0.0014
44 CARDIAC INFECTION 1 0.0013
45 GASTROINTESTINAL HYPOMOTILITY 3 0.0013
46 EYELID EXFOLIATION 1 0.0013
47 DYSBIOSIS 1 0.0012
48 OESOPHAGEAL RUPTURE 1 0.0012
49 HYPERPARATHYROIDISM SECONDARY 3 0.0012
50 PRODUCT CONTAMINATION PHYSICAL 3 0.0012
51 NO ADVERSE EVENT 212 0.0012
52 HEPATIC CANCER METASTATIC 1 0.0012
53 OESOPHAGEAL OBSTRUCTION 1 0.0012
54 THERAPEUTIC PRODUCT CROSS-REACTIVITY 1 0.0011
55 PRODUCT RECONSTITUTION QUALITY ISSUE 1 0.0011
56 VENOUS INJURY 1 0.0011
57 OVARIAN DISORDER 1 0.0011
58 BLADDER CATHETERISATION 1 0.0010
59 EYELID RASH 1 0.0010
60 PRODUCT COMMUNICATION ISSUE 9 0.0010
61 DEVICE RELATED THROMBOSIS 1 0.0010
62 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
63 REDUCED FACIAL EXPRESSION 1 0.0010
64 BREAST ABSCESS 1 0.0010
65 RETINAL TOXICITY 1 0.0010
66 FOREIGN BODY IN THROAT 3 0.0010
67 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
68 INSTILLATION SITE REACTION 1 0.0009
69 DRY AGE-RELATED MACULAR DEGENERATION 1 0.0009
70 FOCAL DYSCOGNITIVE SEIZURES 1 0.0009
71 VOLVULUS 2 0.0008
72 URINARY TRACT OBSTRUCTION 2 0.0008
73 SINUS OPERATION 2 0.0008
74 PRODUCT CONTAMINATION MICROBIAL 1 0.0008
75 COLON OPERATION 1 0.0008
76 RECTAL PROLAPSE 1 0.0008
77 PRODUCT PRESCRIBING ISSUE 18 0.0008
78 END STAGE RENAL DISEASE 15 0.0008
79 PRODUCT TASTE ABNORMAL 11 0.0008
80 INTERVERTEBRAL DISC OPERATION 1 0.0008
81 HYPERAESTHESIA TEETH 1 0.0008
82 COUNTERFEIT PRODUCT ADMINISTERED 1 0.0008
83 PRODUCT PREPARATION ISSUE 5 0.0008
84 ANHEDONIA 20 0.0008
85 OESOPHAGEAL HAEMORRHAGE 1 0.0008
86 INTERCEPTED PRODUCT PRESCRIBING ERROR 1 0.0008
87 IMPAIRED GASTRIC EMPTYING 10 0.0007
88 CALCULUS BLADDER 1 0.0007
89 RENAL ARTERY STENOSIS 1 0.0007
90 NORMOCYTIC ANAEMIA 1 0.0007
91 APRAXIA 1 0.0007
92 THERAPEUTIC PRODUCT EFFECT DELAYED 3 0.0007
93 OSTEOMALACIA 1 0.0006
94 PRODUCT DEPOSIT 1 0.0006
95 ABNORMAL FAECES 5 0.0006
96 GASTROINTESTINAL SOUNDS ABNORMAL 3 0.0006
97 GASTRIC DILATATION 1 0.0006
98 TONSILLECTOMY 1 0.0006
99 ECONOMIC PROBLEM 9 0.0006
100 SEIZURE LIKE PHENOMENA 1 0.0006
101 CARBOHYDRATE ANTIGEN 125 INCREASED 2 0.0006
102 CERVICAL SPINAL STENOSIS 1 0.0006
103 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
104 LUNG TRANSPLANT 2 0.0006
105 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
106 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 3 0.0006
107 NONSPECIFIC REACTION 3 0.0005
108 ESSENTIAL HYPERTENSION 1 0.0005
109 HEART RATE ABNORMAL 3 0.0005
110 BLADDER SPASM 1 0.0005
111 NARCOLEPSY 1 0.0005
112 RADIOTHERAPY 1 0.0005
113 OSTEOPOROTIC FRACTURE 1 0.0005
114 PRODUCT LABEL CONFUSION 3 0.0005
115 CERVIX CARCINOMA 2 0.0005
116 PSYCHIATRIC DECOMPENSATION 1 0.0005
117 OCCULT BLOOD POSITIVE 1 0.0005
118 PROSTATOMEGALY 2 0.0005
119 IMPAIRED QUALITY OF LIFE 7 0.0005
120 PERIODONTITIS 1 0.0005
121 MIDDLE EAR EFFUSION 1 0.0005
122 PRODUCT LOT NUMBER ISSUE 1 0.0005
123 FAECES PALE 1 0.0004
124 SPINAL COLUMN INJURY 1 0.0004
125 PRODUCT USE COMPLAINT 7 0.0004
126 RENAL COLIC 1 0.0004
127 NEPHROGENIC ANAEMIA 2 0.0004
128 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 1 0.0004
129 LEARNING DISORDER 1 0.0004
130 OSTEOPENIA 6 0.0004
131 CHRONIC KIDNEY DISEASE 30 0.0004
132 BOWEL MOVEMENT IRREGULARITY 3 0.0004
133 DRUG TITRATION ERROR 1 0.0004
134 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
135 MULTIPLE ALLERGIES 3 0.0004
136 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
137 RETCHING 8 0.0004
138 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
139 THERAPEUTIC RESPONSE DELAYED 1 0.0004
140 PANCREATIC CARCINOMA METASTATIC 1 0.0004
141 SPINAL OSTEOARTHRITIS 3 0.0003
142 ANAL INCONTINENCE 3 0.0003
143 CENTRAL VENOUS CATHETERISATION 1 0.0003
144 BONE MARROW DISORDER 1 0.0003
145 INGUINAL HERNIA 2 0.0003
146 DYSCHEZIA 1 0.0003
147 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 11 0.0003
148 FAECES DISCOLOURED 7 0.0003
149 BLOOD BLISTER 1 0.0003
150 INJECTION SITE HYPERSENSITIVITY 1 0.0003
151 VITAMIN D DEFICIENCY 3 0.0003
152 RENAL TUBULAR NECROSIS 3 0.0003
153 NEAR DEATH EXPERIENCE 1 0.0003
154 QUALITY OF LIFE DECREASED 4 0.0003
155 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 5 0.0003
156 REGURGITATION 1 0.0003
157 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
158 BLOOD CREATININE ABNORMAL 1 0.0003
159 POLYMENORRHOEA 1 0.0003
160 EAR PRURITUS 1 0.0003
161 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
162 RENAL PAIN 3 0.0003
163 IRRITABLE BOWEL SYNDROME 6 0.0003
164 DENTAL CARIES 3 0.0003
165 NERVE INJURY 3 0.0003
166 BONE LOSS 4 0.0003
167 SNORING 1 0.0003
168 PARANASAL SINUS HYPERSECRETION 1 0.0003
169 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
170 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
171 ORAL INFECTION 1 0.0003
172 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
173 OBSTRUCTION 1 0.0003
174 ABDOMINAL DISTENSION 26 0.0002
175 HOMICIDAL IDEATION 1 0.0002
176 SPINAL STENOSIS 1 0.0002
177 HALLUCINATIONS, MIXED 1 0.0002
178 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
179 PRODUCT DISPENSING ISSUE 1 0.0002
180 PRODUCT CONTAINER ISSUE 2 0.0002
181 TENSION HEADACHE 1 0.0002
182 HORDEOLUM 1 0.0002
183 CHAPPED LIPS 1 0.0002
184 DIVERTICULUM INTESTINAL 1 0.0002
185 TOOTH INFECTION 3 0.0002
186 CATHETERISATION CARDIAC 1 0.0002
187 BONE DENSITY DECREASED 7 0.0002
188 SUSPECTED OFF LABEL USE 1 0.0002
189 DYSPAREUNIA 1 0.0002
190 DEFORMITY 2 0.0002
191 SEASONAL ALLERGY 3 0.0002
192 FOOT FRACTURE 4 0.0002
193 RECALLED PRODUCT ADMINISTERED 2 0.0002
194 RENAL CELL CARCINOMA 1 0.0002
195 BREATH SOUNDS ABNORMAL 1 0.0002
196 HOSPICE CARE 2 0.0002
197 PROTEIN URINE PRESENT 1 0.0002
198 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
199 VULVOVAGINAL PRURITUS 1 0.0002
200 PATHOLOGICAL FRACTURE 1 0.0002
201 EAR DISCOMFORT 2 0.0002
202 PRODUCT COLOUR ISSUE 1 0.0002
203 OSTEOPOROSIS 8 0.0002
204 TOOTH LOSS 4 0.0002
205 MALABSORPTION 1 0.0002
206 WEIGHT FLUCTUATION 2 0.0002
207 EMOTIONAL DISTRESS 23 0.0002
208 ULCER 3 0.0002
209 ANORECTAL DISCOMFORT 1 0.0002
210 HIP SURGERY 1 0.0002
211 ERYTHEMA OF EYELID 1 0.0002
212 BACK INJURY 2 0.0002
213 TOOTH FRACTURE 2 0.0002
214 PRODUCT LEAKAGE 1 0.0002
215 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 36 0.0002
216 SCAR 3 0.0002
217 MOUTH SWELLING 1 0.0002
218 BLOOD URIC ACID INCREASED 1 0.0002
219 SKIN WARM 1 0.0002
220 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
221 HYPERCHLORHYDRIA 1 0.0002
222 DECREASED INTEREST 1 0.0002
223 BRADYKINESIA 1 0.0002
224 HEPATITIS C 2 0.0002
225 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
226 SCREAMING 1 0.0002
227 PROCTALGIA 1 0.0002
228 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
229 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
230 PRODUCT LABEL ISSUE 1 0.0001
231 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
232 PRODUCT PREPARATION ERROR 3 0.0001
233 GASTRIC DISORDER 5 0.0001
234 LARGE INTESTINE POLYP 1 0.0001
235 DEFAECATION URGENCY 1 0.0001
236 BLOOD TEST ABNORMAL 2 0.0001
237 RECTAL HAEMORRHAGE 6 0.0001
238 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
239 RENAL INJURY 4 0.0001
240 COLON CANCER 2 0.0001
241 HYDRONEPHROSIS 1 0.0001
242 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 24 0.0001
243 CONSTIPATION 29 0.0001
244 DERMATITIS ATOPIC 7 0.0001
245 TROPONIN INCREASED 1 0.0001
246 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
247 APNOEA 1 0.0001
248 ABDOMINAL PAIN UPPER 26 0.0001
249 ILLNESS 13 0.0001
250 FURUNCLE 1 0.0001
251 RENAL CYST 1 0.0001
252 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
253 STENT PLACEMENT 1 0.0001
254 FRUSTRATION TOLERANCE DECREASED 1 0.0001
255 MUSCLE DISORDER 1 0.0001
256 BACK DISORDER 2 0.0001
257 MULTIPLE FRACTURES 2 0.0001
258 ESCHERICHIA INFECTION 1 0.0001
259 VOMITING 57 0.0001
260 SPINAL COMPRESSION FRACTURE 1 0.0001
261 MENSTRUAL DISORDER 1 0.0001
262 SECOND PRIMARY MALIGNANCY 1 0.0001
263 SURGERY 7 0.0001
264 RENAL IMPAIRMENT 10 0.0001
265 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
266 ANURIA 1 0.0001
267 BLOOD MAGNESIUM DECREASED 1 0.0001
268 PSYCHOLOGICAL TRAUMA 1 0.0001
269 MUSCLE STRAIN 1 0.0001
270 DISCOMFORT 7 0.0001
271 URINE OUTPUT DECREASED 1 0.0001
272 GOUT 2 0.0001
273 MYOSITIS 1 0.0001
274 BONE DISORDER 2 0.0001
275 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
276 OVARIAN CANCER 1 0.0001
277 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
278 INTESTINAL OBSTRUCTION 4 0.0001
279 LEUKAEMIA 1 0.0001
280 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
281 FLATULENCE 6 0.0001
282 PRODUCT PACKAGING ISSUE 1 0.0001
283 INTENTIONAL DOSE OMISSION 3 0.0001
284 RED BLOOD CELL COUNT DECREASED 3 0.0001
285 DRUG PRESCRIBING ERROR 2 0.0001
286 SINUS BRADYCARDIA 1 0.0001
287 DIZZINESS POSTURAL 1 0.0001
288 KIDNEY INFECTION 2 0.0001
289 THERAPY CHANGE 1 0.0001
290 OVARIAN CYST 1 0.0001
291 BRAIN INJURY 1 0.0001
292 FULL BLOOD COUNT DECREASED 2 0.0001
293 PRODUCT ADMINISTRATION ERROR 2 0.0001
294 TASTE DISORDER 2 0.0001
295 DRY THROAT 1 0.0001
296 ANXIETY 28 0.0001
297 TOOTH ABSCESS 1 0.0001
298 INITIAL INSOMNIA 1 0.0001
299 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
300 HELICOBACTER INFECTION 1 0.0001
301 SCRATCH 1 0.0001
302 INCONTINENCE 1 0.0001
303 CHILLS 11 0.0001
304 NIGHT SWEATS 3 0.0001
305 DECREASED ACTIVITY 1 0.0001
306 ATRIAL FIBRILLATION 9 0.0001
307 SKIN LACERATION 1 0.0001
308 HAEMATOCHEZIA 5 0.0001
309 VENTRICULAR FIBRILLATION 1 0.0001
310 NECK PAIN 5 0.0001
311 MALNUTRITION 1 0.0001
312 RASH PAPULAR 2 0.0001
313 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
314 CHROMATURIA 2 0.0001
315 EYE INFECTION 1 0.0001
316 HEART RATE IRREGULAR 2 0.0001
317 MYOCARDIAL ISCHAEMIA 1 0.0001
318 MICTURITION URGENCY 1 0.0001
319 GASTRIC HAEMORRHAGE 1 0.0001
320 EYE IRRITATION 5 0.0001
321 ELECTROLYTE IMBALANCE 1 0.0001
322 ABDOMINAL PAIN 20 0.0001
323 RENAL DISORDER 4 0.0001
324 BLOOD IRON DECREASED 1 0.0001
325 MACULAR DEGENERATION 1 0.0001
326 MUSCLE RIGIDITY 1 0.0001
327 WRIST FRACTURE 1 0.0001
328 RENAL FAILURE 11 0.0001
329 BURSITIS 1 0.0001
330 NOCTURIA 1 0.0001
331 ILEUS 1 0.0001
332 AGEUSIA 2 0.0001
333 DERMATITIS ALLERGIC 1 0.0001
334 HIATUS HERNIA 1 0.0001
335 BLOOD CREATININE INCREASED 5 0.0001
336 NERVOUSNESS 4 0.0001
337 HAND DEFORMITY 1 0.0001
338 IMMUNE SYSTEM DISORDER 1 0.0001
339 ANKYLOSING SPONDYLITIS 1 0.0001
340 PULMONARY CONGESTION 1 0.0001
341 OROPHARYNGEAL PAIN 7 0.0001
342 EAR INFECTION 2 0.0001
343 PAIN 46 0.0001
344 MALIGNANT MELANOMA 1 0.0001
345 SINUS CONGESTION 1 0.0001
346 RASH PRURITIC 4 0.0001
347 LIMB INJURY 2 0.0001
348 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
349 DIVERTICULITIS 2 0.0001
350 ORAL DISCOMFORT 1 0.0001
351 FEELING COLD 2 0.0001
352 HYPOMAGNESAEMIA 1 0.0001
353 HUNGER 1 0.0001
354 BLISTER 4 0.0001
355 DYSPEPSIA 7 0.0001
356 SLEEP DISORDER 5 0.0001
357 NAUSEA 56 0.0001
358 BRONCHOSPASM 1 0.0001
359 THERAPY INTERRUPTED 5 0.0001
360 SYNCOPE 7 0.0001
361 HYPERSOMNIA 2 0.0001
362 DIARRHOEA 45 0.0001
363 LETHARGY 4 0.0001
364 ACCIDENTAL UNDERDOSE 1 0.0001
365 DYSPHONIA 4 0.0001
366 URINARY INCONTINENCE 2 0.0001
367 DEHYDRATION 9 0.0001
368 HYPOAESTHESIA ORAL 1 0.0001
369 UNEVALUABLE EVENT 5 0.0001
370 INCORRECT DOSE ADMINISTERED 15 0.0001
371 ABDOMINAL DISCOMFORT 11 0.0001
372 NEPHROLITHIASIS 3 0.0001
373 INSURANCE ISSUE 1 0.0001
374 ACUTE KIDNEY INJURY 10 0.0001
375 DEVICE RELATED INFECTION 1 0.0001
376 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
377 LYMPHOMA 1 0.0001
378 ANKLE FRACTURE 1 0.0001
379 WEIGHT DECREASED 18 0.0001
380 BRAIN FOG 1 0.0001
381 RESPIRATORY TRACT CONGESTION 1 0.0001
382 CYSTITIS 2 0.0001
383 OBESITY 1 0.0001
384 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
385 HIP FRACTURE 2 0.0001
386 ASTHMA 7 0.0001
387 RHINORRHOEA 4 0.0001
388 DEPRESSION 14 0.0001
389 METASTASES TO BONE 1 0.0001
390 IMPAIRED HEALING 2 0.0001
391 OSTEONECROSIS 2 0.0001
392 VENTRICULAR TACHYCARDIA 1 0.0001
393 URINARY RETENTION 2 0.0001
394 ANGER 2 0.0001
395 NIGHTMARE 2 0.0001
396 PRODUCT STORAGE ERROR 5 0.0001
397 METASTASES TO LIVER 1 0.0001
398 COLD SWEAT 1 0.0001
399 PRODUCT USE IN UNAPPROVED INDICATION 14 0.0001
400 HEAD DISCOMFORT 1 0.0001
401 GASTROINTESTINAL DISORDER 5 0.0001
402 TOOTHACHE 1 0.0001
403 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
404 PRODUCT DOSE OMISSION ISSUE 16 0.0001
405 DYSURIA 2 0.0001
406 OFF LABEL USE 47 0.0001
407 THINKING ABNORMAL 1 0.0001
408 BACTERIAL INFECTION 1 0.0001
409 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
410 DYSARTHRIA 2 0.0001
411 DYSPNOEA EXERTIONAL 2 0.0001
412 FRACTURE 1 0.0001
413 DYSPHAGIA 5 0.0001
414 BLOOD URINE PRESENT 1 0.0001
415 SLEEP APNOEA SYNDROME 1 0.0001
416 INCREASED APPETITE 1 0.0001
417 PULMONARY FIBROSIS 1 0.0001
418 HOSPITALISATION 8 0.0001
419 LOWER LIMB FRACTURE 1 0.0001
420 PRURITUS 20 0.0001
421 PERIPHERAL SWELLING 8 0.0001
422 HERNIA 1 0.0001
423 ERUCTATION 1 0.0001
424 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
425 HAEMORRHOIDS 1 0.0001
426 CHOKING 1 0.0001
427 SINUS DISORDER 1 0.0001
428 HEART RATE INCREASED 5 0.0001
429 BLOOD PRESSURE ABNORMAL 1 0.0001
430 PRESCRIBED UNDERDOSE 1 0.0001
431 SPINAL FRACTURE 1 0.0000
432 JOINT SWELLING 6 0.0000
433 PRODUCT PHYSICAL ISSUE 1 0.0000
434 PSORIATIC ARTHROPATHY 2 0.0000
435 INJURY ASSOCIATED WITH DEVICE 1 0.0000
436 BODY TEMPERATURE INCREASED 1 0.0000
437 INJECTION SITE WARMTH 1 0.0000
438 RIB FRACTURE 1 0.0000
439 DERMATITIS 1 0.0000
440 KNEE ARTHROPLASTY 1 0.0000
441 MOUTH ULCERATION 1 0.0000
442 SKIN EXFOLIATION 4 0.0000
443 HYPERTENSION 10 0.0000
444 IMPAIRED WORK ABILITY 1 0.0000
445 SKIN CANCER 1 0.0000
446 COUGH 13 0.0000
447 DIZZINESS 23 0.0000
448 AMNESIA 3 0.0000
449 FEELING ABNORMAL 11 0.0000
450 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
451 MELAENA 1 0.0000
452 TOOTH DISORDER 1 0.0000
453 NEOPLASM MALIGNANT 3 0.0000
454 ORAL PAIN 1 0.0000
455 HEADACHE 28 0.0000
456 DRUG INEFFECTIVE 58 0.0000
457 PRODUCT AVAILABILITY ISSUE 1 0.0000
458 MUSCLE SPASMS 8 0.0000
459 HYPOKALAEMIA 2 0.0000
460 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
461 COGNITIVE DISORDER 2 0.0000
462 ARRHYTHMIA 2 0.0000
463 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
464 MIGRAINE 4 0.0000
465 INFECTION 6 0.0000
466 PRESYNCOPE 1 0.0000
467 UNDERDOSE 3 0.0000
468 LIVER INJURY 1 0.0000
469 ALOPECIA 8 0.0000
470 ENCEPHALOPATHY 1 0.0000
471 DYSPNOEA 23 0.0000
472 PNEUMONIA 13 0.0000
473 HALLUCINATION 3 0.0000
474 PRODUCT COMPLAINT 1 0.0000
475 FLUID RETENTION 2 0.0000
476 BLOOD PRESSURE INCREASED 6 0.0000
477 LOSS OF CONSCIOUSNESS 5 0.0000
478 HAEMOGLOBIN DECREASED 4 0.0000
479 ANAPHYLACTIC SHOCK 1 0.0000
480 BACK PAIN 9 0.0000
481 SKIN ULCER 1 0.0000
482 HAEMATOMA 1 0.0000
483 ECZEMA 2 0.0000
484 SEDATION 1 0.0000
485 GASTRITIS 1 0.0000
486 FREQUENT BOWEL MOVEMENTS 1 0.0000
487 ANAEMIA 7 0.0000
488 MOOD ALTERED 1 0.0000
489 GAIT DISTURBANCE 7 0.0000
490 MALAISE 16 0.0000
491 MEMORY IMPAIRMENT 5 0.0000
492 ANAPHYLACTIC REACTION 2 0.0000
493 TREMOR 6 0.0000
494 FALL 12 0.0000
495 FATIGUE 28 0.0000
496 URTICARIA 6 0.0000
497 DEMENTIA 1 0.0000
498 HYPONATRAEMIA 2 0.0000
499 PAIN IN JAW 1 0.0000
500 URINARY TRACT INFECTION 6 0.0000
501 PRODUCT SUBSTITUTION ISSUE 2 0.0000
502 BALANCE DISORDER 3 0.0000
503 DYSSTASIA 1 0.0000
504 PALPITATIONS 4 0.0000
505 PSYCHOTIC DISORDER 1 0.0000
506 RESPIRATORY DISORDER 1 0.0000
507 ADVERSE DRUG REACTION 3 0.0000
508 LACRIMATION INCREASED 1 0.0000
509 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
510 THERAPEUTIC RESPONSE DECREASED 2 0.0000
511 FEELING HOT 2 0.0000
512 DRUG ADMINISTRATION ERROR 1 0.0000
513 ADVERSE EVENT 3 0.0000
514 LIMB DISCOMFORT 1 0.0000
515 CARDIAC DISORDER 3 0.0000
516 ASTHENIA 12 0.0000
517 HEAD INJURY 1 0.0000
518 MOVEMENT DISORDER 1 0.0000
519 DRUG INTOLERANCE 3 0.0000
520 PRODUCT DOSE OMISSION 2 0.0000
521 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
522 DECREASED APPETITE 7 0.0000
523 FUNGAL INFECTION 1 0.0000
524 INJECTION SITE PRURITUS 2 0.0000
525 RASH 13 0.0000
526 TYPE 2 DIABETES MELLITUS 1 0.0000
527 HEPATIC ENZYME INCREASED 2 0.0000
528 CHEST DISCOMFORT 3 0.0000
529 ERYTHEMA 6 0.0000
530 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
531 NEOPLASM PROGRESSION 1 0.0000
532 RASH MACULAR 1 0.0000
533 BURNING SENSATION 2 0.0000
534 HYPERKALAEMIA 1 0.0000
535 HEART RATE DECREASED 1 0.0000
536 LYMPHADENOPATHY 1 0.0000
537 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
538 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
539 MOBILITY DECREASED 2 0.0000
540 CRYING 1 0.0000
541 RESPIRATORY FAILURE 2 0.0000
542 RESTLESSNESS 1 0.0000
543 NASOPHARYNGITIS 5 0.0000
544 PRODUCT USE ISSUE 5 0.0000
545 HOT FLUSH 2 0.0000
546 MUSCULAR WEAKNESS 3 0.0000
547 COLITIS 1 0.0000
548 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
549 ARTHRITIS 2 0.0000
550 ABNORMAL BEHAVIOUR 1 0.0000
551 DISORIENTATION 1 0.0000
552 HYPOTENSION 5 0.0000
553 CARDIAC FAILURE 2 0.0000
554 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
555 DEVICE BREAKAGE 1 0.0000
556 DYSKINESIA 1 0.0000
557 LUNG NEOPLASM MALIGNANT 1 0.0000
558 INFLUENZA LIKE ILLNESS 2 0.0000
559 DRUG ABUSE 2 0.0000
560 RHABDOMYOLYSIS 1 0.0000
561 POLLAKIURIA 1 0.0000
562 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
563 ROAD TRAFFIC ACCIDENT 1 0.0000
564 WITHDRAWAL SYNDROME 1 0.0000
565 MYALGIA 4 0.0000
566 HYPOACUSIS 1 0.0000
567 MENTAL DISORDER 1 0.0000
568 MUSCULOSKELETAL STIFFNESS 2 0.0000
569 DRUG WITHDRAWAL SYNDROME 2 0.0000
570 COLITIS ULCERATIVE 1 0.0000
571 WEIGHT INCREASED 5 0.0000
572 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
573 THERAPY NON-RESPONDER 1 0.0000
574 VISION BLURRED 3 0.0000
575 SKIN IRRITATION 1 0.0000
576 SKIN DISCOLOURATION 1 0.0000
577 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
578 SWELLING 2 0.0000
579 NEUROPATHY PERIPHERAL 2 0.0000
580 PRODUCTIVE COUGH 1 0.0000
581 CONTUSION 2 0.0000
582 HYPOGLYCAEMIA 1 0.0000
583 PAIN IN EXTREMITY 6 0.0000
584 HYPOAESTHESIA 3 0.0000
585 DRY EYE 1 0.0000
586 SOMNOLENCE 4 0.0000
587 CONDITION AGGRAVATED 6 0.0000
588 FLUSHING 2 0.0000
589 SINUSITIS 2 0.0000
590 THERAPY CESSATION 1 0.0000
591 MUSCULOSKELETAL PAIN 1 0.0000
592 SPEECH DISORDER 1 0.0000
593 PARAESTHESIA 3 0.0000
594 DEPRESSED MOOD 1 0.0000
595 PLATELET COUNT DECREASED 2 0.0000
596 DRUG DEPENDENCE 3 0.0000
597 DRUG EFFECT DECREASED 1 0.0000
598 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
599 OEDEMA 1 0.0000
600 DRUG DOSE OMISSION 3 0.0000
601 ARTHROPATHY 1 0.0000
602 INFLUENZA 2 0.0000
603 EYE PAIN 1 0.0000
604 RHEUMATOID ARTHRITIS 2 0.0000
605 SEIZURE 2 0.0000
606 COVID-19 3 0.0000
607 BONE PAIN 1 0.0000
608 NASAL CONGESTION 1 0.0000
609 WHEEZING 1 0.0000
610 ARTHRALGIA 7 0.0000
611 CATARACT 1 0.0000
612 ILL-DEFINED DISORDER 1 0.0000
613 CHEST PAIN 3 0.0000
614 PSORIASIS 2 0.0000
615 DEATH 13 0.0000
616 BLOOD PRESSURE DECREASED 1 0.0000
617 INJURY 1 0.0000
618 DYSGEUSIA 1 0.0000
619 EPISTAXIS 1 0.0000
620 ACNE 1 0.0000
621 INJECTION SITE SWELLING 1 0.0000
622 CARDIAC FAILURE CONGESTIVE 1 0.0000
623 PROSTATE CANCER 1 0.0000
624 CONFUSIONAL STATE 2 0.0000
625 DRY MOUTH 1 0.0000
626 TREATMENT FAILURE 1 0.0000
627 PYREXIA 4 0.0000
628 MYOCARDIAL INFARCTION 2 0.0000
629 INTENTIONAL PRODUCT MISUSE 1 0.0000
630 INSOMNIA 3 0.0000
631 SUICIDAL IDEATION 1 0.0000
632 BLOOD GLUCOSE INCREASED 2 0.0000
633 HAEMORRHAGE 1 0.0000
634 DISEASE PROGRESSION 1 0.0000
635 OEDEMA PERIPHERAL 1 0.0000
636 VISUAL IMPAIRMENT 1 0.0000
637 INJECTION SITE ERYTHEMA 1 0.0000
638 HYPERHIDROSIS 1 0.0000
639 DRY SKIN 1 0.0000
640 PRODUCT QUALITY ISSUE 1 0.0000
641 NEUTROPENIA 1 0.0000
642 INJECTION SITE PAIN 2 0.0000
643 CEREBROVASCULAR ACCIDENT 1 0.0000
644 HYPERSENSITIVITY 1 0.0000
645 OVERDOSE 1 0.0000